Hugh (Heungnam) Kim

Hugh (Heungnam) Kim has a diverse work experience in the field of scientific research and development. Hugh (Heungnam) currently holds the position of Senior Research Scientist at OmniAb, Inc. since February 2023. Prior to this, Hugh worked as a Senior Scientist II at 3T Biosciences from December 2021 to October 2022.

Before that, they served as a Senior Scientist at Gritstone Oncology from May 2019 to November 2021, and at Hengenix Biotech, Inc. from December 2017 to May 2019. Hugh also gained valuable experience as a Scientist at Roche Molecular Systems from January 2016 to July 2017, where they focused on the development of rabbit monoclonal antibodies for tissue diagnostics.

Furthermore, they served as a Senior Scientist at Biocare Medical LLC. from September 2012 to January 2016 and as a Basic Life Science Research Associate at Stanford University from November 2011 to September 2012.

Their career in research began at the National Institutes of Health/ NCI/Laboratory of Molecular Biology/Antibody Therapy Unit, where they held various roles including Research Fellow and Visiting Fellow from April 2003 to April 2011.

Overall, Hugh (Heungnam) Kim has accumulated extensive experience in the scientific research field, with expertise in antibody development and diagnostics.

Hugh (Heungnam) Kim obtained their Ph.D. in Environmental Health Science from the University of Occupational and Environmental Health Japan, where they studied from 1999 to 2003.